Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap | 1.90B | P/E | - | EPS this Y | - | Ern Qtrly Grth | -6.20% |
Income | 408.5M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -10.00% |
Sales | 1.17B | PEG | - | EPS past 5Y | - | 200D Avg Chg | -10.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -32.00% | |
Recommedations | - | Quick Ratio | 0.75 | Shares Outstanding | 57M | 52W Low Chg | 23.00% |
Insider Own | - | ROA | - | Shares Float | - | Beta | - |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 33.33 |
Gross Margin | 68.66% | Profit Margin | 34.94% | Avg. Volume | 3,478,730 | Target Price | - |
Oper. Margin | 41.31% | Earnings Date | - | Volume | 132,301 | Change | -9.33% |
About Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.